Skip to main content
In stock|Targeted Therapy (Investigational)

Debio 1347 (FGFR Inhibitor)

Oncology TypeSolid Tumour
Drug Class / MechanismFGFR Inhibitor
No Image
Description

Debio 1347 (FGFR Inhibitor) is classified as a FGFR Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational)
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3